Fundz

MaaT Pharma Appoints Gianfranco Pittari, M.D., Ph.D., as Chief Medical Officer

PRIVATEJun 24, 2024

Position

Chief Executive Officer

Company

MaaT Pharma

Hervé Affagard
haffagard@maat-pharma.com
LyonBiotechnologyHealth CareTherapeutics

Description

MaaT Pharma has announced the appointment of Gianfranco Pittari, M.D., Ph.D., as their Chief Medical Officer. Dr. Pittari brings over 15 years of international experience in clinical research and drug development in hematology, oncology, and immunology.

Quick answer

MaaT Pharma Appoints Gianfranco Pittari, M.D., Ph.D., as Chief Medical Officer (June 24, 2024). MaaT Pharma is based in Lyon, Auvergne Rhône Alpes, France.

What did MaaT Pharma announce on June 24, 2024?
MaaT Pharma has announced the appointment of Gianfranco Pittari, M.D., Ph.D., as their Chief Medical Officer. Dr. Pittari brings over 15 years of international experience in clinical research and drug development in hematology, oncology, and immunology.
What does MaaT Pharma do?
MaaT Pharma is a clinical-stage biotechnology company, leading in the development of Microbiome Ecosystem TherapiesTM (MET)1 to improve the survival of patients with cancer.
Where is MaaT Pharma based?
MaaT Pharma is based in Lyon, Auvergne Rhône Alpes, France.
Which similar companies made leadership changes around the same time?
Avalo Therapeutics (June 24, 2024), Arvinas (June 24, 2024), MBX Biosciences, Inc. (June 25, 2024) and Actym Therapeutics (June 25, 2024) also announced leadership changes within 45 days of MaaT Pharma.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at MaaT Pharma, and when

A new leader at MaaT Pharma brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day MaaT Pharma raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at MaaT Pharma, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at MaaT Pharma. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

MaaT Pharma

Location

Lyon, Auvergne Rhône Alpes, France

About

MaaT Pharma is a clinical-stage biotechnology company, leading in the development of Microbiome Ecosystem TherapiesTM (MET)1 to improve the survival of patients with cancer. The company is committed to restoring the microbiome/host symbiosis of patients with cancer and graft versus host disease (GvHD). MaaT Pharma has launched a Phase 3 clinical trial in Europe for patients with acute GvHD, after demonstrating the concept in a Phase 2 clinical trial.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment MaaT Pharma changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Jonathan
Likely contact at this company
••••••••@••••••••

See Jonathan's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for MaaT Pharma's next move

Learn about Strategic plan

MaaT Pharma changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.